Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Phase I studies establish feasibility, tolerability of oral delivery of heparin

Oct. 26, 1998

Endorex/Elan joint venture to develop Medipad-based drugs

Oct. 26, 1998

First high-affinity, nonpeptide BB1, BB2 receptor antagonists designed at Parke-Davis

Oct. 26, 1998

Millennium BioTherapeutics to use Abgenix human antibody technology

Oct. 21, 1998

Aradigm licenses new aerosol technology from Spanish university

Oct. 21, 1998

Clinical trial results reported, development plans outlined for Aastrom stem cell therapy system

Oct. 20, 1998

Xenova and Warner-Lambert extend NatChem drug discovery collaboration

Oct. 19, 1998

Genset, Pharmacia & Upjohn collaborate in pharmacogenomics research

Oct. 14, 1998

Myriad Genetics, Schering AG collaborate on new drug development

Oct. 9, 1998

ThromboSol effectively preserves platelet function and cell recovery in in vivo study

Oct. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...